View All Jobs 28392

Senior Cell Therapy Account Manager - New Orleans

Own the account strategy and execution for academic hospitals and referral networks in New Orleans
New Orleans, Louisiana, United States
Senior
$177,905 – 230,230 USD / year
20 hours agoBe an early applicant
Kite Pharma

Kite Pharma

Develops and commercializes engineered cell therapies, particularly CAR T-cell treatments, for hematologic cancers and other serious diseases.

2 Similar Jobs at Kite Pharma

Cell Therapy Account Manager (CTAM)

The Cell Therapy Account Manager (CTAM) is the commercial account lead for designated academic hospitals (ATC) and surrounding community networks (referral networks). This role is responsible for driving demand, across Brand and CART class share and ensuring the successful adoption of Kite CAR T therapies through strategic account ownership, cross functional collaboration, and deep clinical expertise.

The CTAM owns the performance of assigned Authorized Treatment Centers (ATCs) and community referral networks, serving as the primary point of accountability for account strategy, execution, and results.

Territory: New Orleans, LA

This is a field-based position based in New Orleans, LA. Candidates should reside within 20 miles of the geography

Key Responsibilities

  • Own overall performance, strategy, and execution for assigned ATCs and associated referral networks
  • Drive appropriate patient identification, referral, and therapy adoption through compliant education and engagement
  • Differentiate Kite CAR T therapies versus alternative options using approved messaging
  • Develop and execute comprehensive account and territory plans aligned with regional and national priorities
  • Deliver against defined sales goals, KPIs, and growth objectives

Stakeholder Engagement & Relationship Leadership

  • Build trusted relationships with treating physicians, referrers, transplant teams, administrators, and key influencers
  • Navigate complex academic and integrated delivery networks to align priorities and remove barriers to care
  • Lead engagement across multiple stakeholders to support class and brand growth
  • Represent Kite at scientific congresses, speaker programs, and peer to peer educational forums

Patient Access & Cell Therapy Coordination

  • Identify, map, and optimize patient referral pathways within hematology and oncology networks
  • Partner with cross functional peers to support patient access, reimbursement education, and logistical coordination
  • Support ATC readiness and comfort with CAR T processes to enable demand generation

Cross Functional Leadership & Collaboration

  • Act as the "quarterback" across Medical, Market Access, Operations, and ATC Onboarding teams
  • Provide timely insights on account trends, competitive dynamics, and market opportunities
  • Influence resource prioritization to address account specific needs and growth opportunities
  • Ensure all activities are executed in compliance with company policies

Success in This Role Looks Like

  • Sustained growth in referrals (Class) and treated patients (Brand)
  • Strong, trusted partnerships across key stakeholders within each account
  • Consistent execution of strategic account plans that drive brand and class share
  • Proactive identification and resolution of access, operational, and market barriers
  • High standards of compliance, professionalism, and cross functional collaboration

Basic Qualifications

  • PhD/ PharmD with 2+ years of rare disease, Hematology/Oncology, or complex account experience - OR
  • Master's degree with 6+ years of rare disease, Hematology/Oncology, or complex account experience - OR
  • Bachelor's degree with 8+ years of rare disease, Hematology/Oncology, or complex account experience

Preferred Qualifications

  • Bachelor's degree with 6+ years of commercial sales experience (or equivalent combinations of education and experience)
  • Proven success in rare disease pharmaceutical, Hematology/Oncology, or complex account sales
  • Hematology/oncology or cell therapy experience
  • Experience managing large, sophisticated accounts with multiple stakeholders
  • Strong business acumen, planning, and execution skills
  • Ability to work independently and within matrix team environment in a fast paced, field-based environment
  • Willingness to travel approximately 25%
  • Launch experience within academic hospital or transplant center settings
  • Demonstrated ability to lead cross functional account teams without direct authority
  • Elite selling skills backed by a proven track record of success. Ability to identify specific, appropriate patients and gain a meaningful commitment from treaters and referrers.
  • Strong analytical skills with the ability to translate data into actionable strategy

Core Competencies

  • Customer Focus; Patient Centric
  • Results Driven
  • Rare Disease mindset with a proven history of perseverance and appropriate patient identification.
  • Demonstrated perseverance needed to successfully compete in rare disease space.
  • Strategic Thinker and ability to work in matrix environment
  • Cross Functional Leadership
  • Strong Business & Analytical Acumen
  • Integrity, Compliance & Trust

The salary range for this position is: $177,905.00 - $230,230.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

* Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

+ Show Original Job Post
























Senior Cell Therapy Account Manager - New Orleans
New Orleans, Louisiana, United States
$177,905 – 230,230 USD / year
Customer Success
About Kite Pharma
Develops and commercializes engineered cell therapies, particularly CAR T-cell treatments, for hematologic cancers and other serious diseases.